Sign In
Buy CRSP
$48.15
+1.16 (+2.47%)
At Close: Jul 21, 2026
Investing in These 3 Stocks Now Could Make You a Millionaire Retiree
05:50am, Saturday, 25'th Nov 2023
Amazon has plenty of room to grow despite its already huge size. CRISPR Therapeutics is at a pivotal point, with U.S. approvals for its lead candidate potentially on the way.
CRISPR-Cas9 Gene Editing Is On The Cusp Of Something Big
03:39am, Saturday, 25'th Nov 2023
Gene editing, also known as genome editing, allows scientists to modify the DNA of organisms using biotechnological techniques. CRISPR-Cas9 is the most widely used gene editing technology, known for i
CRISPR (CRSP) Rises More Than 40% in Past 3 Months: Here's Why
01:32pm, Friday, 24'th Nov 2023
CRISPR (CRSP) expects a potential approval for its gene-edited therapy, Casgevy (exa-cel) in the United States for treating two debilitating blood disorders. The drug has been recently approved in the
5 Biotech Stocks Likely to Thrive as Industry Prospects Look Bright
09:46am, Wednesday, 22'nd Nov 2023
New drug approvals and pipeline progress are likely to help maintain momentum for the Zacks Biomedical and Genetics industry. A strong portfolio and solid pipeline progress position GILD, CRSP, ACAD,
3 Biotech Stocks That Could Be Millionaire Makers
05:30am, Wednesday, 22'nd Nov 2023
There are several paths to millionaire status, and investing is one of them. But to give yourself a chance to become a millionaire this way, it's important to buy a diverse basket of solid companies a
3 Monster Stocks in the Making
06:49am, Saturday, 18'th Nov 2023
Beam Therapeutics develops highly promising base-editing therapies. CRISPR Therapeutics could soon have its first product on the market in the U.S. Sarepta Therapeutics is a leader in treating rare ge
3 Cathie Wood You'll Regret Not Buying Soon: November 2023
03:11pm, Thursday, 16'th Nov 2023
Cathie Wood is as bullish as ever, but recent economic indicators point to strength for her favorite stocks. In an interview, Cathie Wood emphasized that deflation is now a key concern rather than inf
CRISPR (CRSP), Vertex Get UK Nod for First Gene Therapy Casgevy
01:32pm, Thursday, 16'th Nov 2023
CRISPR (CRSP) and Vertex's Casgevy, the first-ever gene-edited therapy, to treat sickle cell disease and transfusion-dependent beta thalassemia gets MHRA nod. Stock rises in pre-market trading.
Crispr Therapeutics, Vertex get world's first regulatory green light for CRISPR-based medicine
08:49am, Thursday, 16'th Nov 2023
Shares of Crispr Therapeutics CRSP, +1.68% and Vertex Pharmaceuticals Inc. VRTX, -5.57% gained ground premarket on Thursday after the companies got the world's first regulatory authorization for a med
CRISPR Therapeutics (CRSP) Stock Jumps as U.K. Authorizes Gene Therapy
08:46am, Thursday, 16'th Nov 2023
CRISPR Therapeutics (NASDAQ: CRSP ) stock rose 5% on news the U.K. gave conditional marketing authority to its gene therapy for sickle cell anemia. It's the first authorization in the world for the CR
Can CRISPR Therapeutics Stock Double in 5 Years? Here's What It Would Take.
05:30am, Thursday, 16'th Nov 2023
CRISPR Therapeutics shares have advanced this year, but they're still far from their peak. The company is heading for its biggest moment ever: potential product approval.
Invest in the Future With These 7 Forever Stocks
01:55pm, Wednesday, 15'th Nov 2023
One of my favorite investment strategies when seeking forever stocks is to look to past trends that turned stale. Think of some of the hottest sectors in the past five years that saw massive investor
3 Biotech Stocks With Key Catalysts Coming in December
01:26pm, Wednesday, 15'th Nov 2023
Some of the most exciting opportunities can be found in biotech stocks. In fact, find one with a powerful catalyst just around the corner, and you can make a good deal of money.
2 Stocks to Buy Hand Over Fist as the S&P 500 Rockets Higher
05:00am, Tuesday, 14'th Nov 2023
Growth stocks could lead this latest market rally -- and may deliver growth to your portfolio over time. Amazon and CRISPR Therapeutics are well positioned to benefit from the next bull market.
3 Biotech Stocks That Are Poised to Have Breakthroughs in 2024
08:18am, Sunday, 12'th Nov 2023
When it comes to biotech stocks, I usually like to take a “Goldilocks” approach. This involves investing in biotech companies that have one or more promising drugs in mid-to-late stage clinical tr
